XHKG
2298
Market cap67mUSD
Oct 09, Last price
0.24HKD
1D
0.41%
1Q
-23.75%
Jan 2017
-91.87%
IPO
-93.03%
Name
Cosmo Lady (China) Holdings Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cosmo Lady (China) Holdings Company Limited functions as an investment holding firm primarily involved in the design, development, research, and distribution of branded intimate apparel goods across the People's Republic of China. Its diverse product portfolio encompasses bras, underwear, sleepwear, loungewear, and thermal clothing, alongside items such as leggings, tights, vests, hosiery, and fashion accessories. These products are marketed under various brand names, including Cosmo Lady, Cosmo Elegance, Cosmo Blossom, Cosmo Esquire, Secret of City Beauty, Freeday, Rubii, Ilsée, Ordifen, and Ordifen+. Beyond its core product offerings, the company also delivers services in logistics, warehousing, distribution, property management, brand management, corporate consulting, and computer technology. Consumers can purchase its products through a multi-channel strategy, utilizing company-owned stores, franchised outlets, shopping mall locations, and its robust e-commerce platform. The company was founded in 1998 and maintains its headquarters in Dongguan, China.
Key people
Yaonan Zheng
Chief Executive Officer, Executive Chairman of the Board · since 2021
Chief Financial Officer, Vice President, Company Secretary · since 2022
Yu-in Mao
Vice President
Xiaoli Wu
Vice President, Executive Director · since 2014
Shengfeng Zhang
Executive Deputy Chairman of the Board, Vice President · since 2014
Executive Director · since 2023
Shuang Sha
senior vice president and Chief Executive officer for Ordifen brand business of the Group · since 2020
Wei Xiao
Supply Chain Management
Xiangying Kong
Non-Executive Director · since 2022
Zonghong Lin
Non-Executive Director · since 2019
Zhigang Chen
Non-Executive Independent Director · since 2014
Non-Executive Independent Director · since 2014
Non-Executive Independent Director · since 2017
Chi Ming Yau
Non-Executive Independent Director · since 2014
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||